One-year clinical and computed tomography follow-up after implantation of bioresorbable vascular scaffolds in patients with coronary chronic total occlusions.

about

One-year clinical and computed tomography follow-up after implantation of bioresorbable vascular scaffolds in patients with coronary chronic total occlusions.

Item

http://www.wikidata.org/entity/Q48130911

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

One-year clinical and computed ...... nary chronic total occlusions.

@en

One-year clinical and computed ...... nary chronic total occlusions.

@nl

type

Item

label

One-year clinical and computed ...... nary chronic total occlusions.

@en

One-year clinical and computed ...... nary chronic total occlusions.

@nl

prefLabel

One-year clinical and computed ...... nary chronic total occlusions.

@en

One-year clinical and computed ...... nary chronic total occlusions.

@nl

P1476

One-year clinical and computed ...... onary chronic total occlusions

@en

P2093

Bruno Pereira

http://www.w3.org/2001/XMLSchema#string

Carlos Van Mieghem

http://www.w3.org/2001/XMLSchema#string

David Verhaert

http://www.w3.org/2001/XMLSchema#string

Emanuele Barbato

http://www.w3.org/2001/XMLSchema#string

Endry Willems

http://www.w3.org/2001/XMLSchema#string

Jo Dens

http://www.w3.org/2001/XMLSchema#string

Mathias Vrolix

http://www.w3.org/2001/XMLSchema#string

Peter Frambach

http://www.w3.org/2001/XMLSchema#string

P2860

Bioresorbable scaffolds: rationale, current status, challenges, and future.

A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an interim 1-year analysis of clinical and procedural secondary outcomes

Bioresorbable Scaffolds versus Metallic Stents in Routine PCI.

A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods.

Angiographic and optical coherence tomography insights into bioresorbable scaffold thrombosis: single-center experience

Clinical end points in coronary stent trials: a case for standardized definitions.

First serial assessment at 6 months and 2 years of the second generation of absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study.

Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial.

Possible mechanical causes of scaffold thrombosis: insights from case reports with intracoronary imaging.

Percutaneous coronary intervention for chronic total occlusion of the coronary artery with the implantation of bioresorbable everolimus-eluting scaffolds. Poznan CTO-Absorb Pilot Registry.

P304

488-496

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CCD.27390

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Joren Maeremans

P577

2017-10-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29068171

http://www.w3.org/2001/XMLSchema#string